CN203724635U - Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus - Google Patents
Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus Download PDFInfo
- Publication number
- CN203724635U CN203724635U CN201420079318.9U CN201420079318U CN203724635U CN 203724635 U CN203724635 U CN 203724635U CN 201420079318 U CN201420079318 U CN 201420079318U CN 203724635 U CN203724635 U CN 203724635U
- Authority
- CN
- China
- Prior art keywords
- module
- patient
- portable
- therapeutic apparatus
- sleep apnea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 21
- 208000001797 obstructive sleep apnea Diseases 0.000 title claims abstract description 17
- 201000002859 sleep apnea Diseases 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 claims abstract description 10
- 208000011580 syndromic disease Diseases 0.000 claims description 10
- 230000036772 blood pressure Effects 0.000 claims description 6
- 208000024891 symptom Diseases 0.000 abstract description 6
- 230000004118 muscle contraction Effects 0.000 abstract description 5
- 230000005284 excitation Effects 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract 1
- 238000004088 simulation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- 210000005181 root of the tongue Anatomy 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 206010003497 Asphyxia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010057344 Pharyngeal hypertrophy Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
Abstract
The utility model discloses a portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus. The therapeutic apparatus comprises a host, output wires and electrode plates. The host of the therapeutic apparatus is composed of five modules comprising a central processing module, a man-machine interaction module, a programmable logic module, a power supply module and an output module. Genioglossus is stimulated and exercised through the electrode plates attached under the chin of a patient, and nervous excitation and tongue root muscle contraction are caused by chin skin simulation, so the obstruction of the upper airway is relieved and the symptom is relieved, so that when the therapeutic apparatus is used for a long time, the tongue root muscle contraction capability of the patient can be repaired, the tension of the upper airway dilator can be improved, and the improving or even healing effect can be achieved. The therapeutic apparatus can be carried by the patient conveniently during a business trip, advantages of great patient compliance and more applicable patients can be realized, the 220V mains supply is not used, and what the patient needs to do is to attach the electrode plates at the prominentia laryngea during treatment, so advantages of convenient operation and simple utilization can be realized.
Description
technical field:
This utility model relates to a kind of electronic therapeutic instrument, especially a kind of portable obstructive sleep apnea low syndrome instrument.
background technology:
Obstructive sleep apnea low syndrome (OSAHS) is a kind of sleep-respiratory disease, clinical manifestation have nighttime sleep snoring companion asphyxia and daytime drowsiness.Because asphyxia causes hypoxia at night and the hypercapnia of repeatedly showing effect, can cause hypertension, coronary heart disease, the complication such as diabetes and cerebrovascular disease and vehicle accident, even occur sudden death at night, so OSAHS is a kind of sleep-respiratory disease that has potential lethal.
For the treatment of OSAHS, mainly contain clinically following several therapeutic modality:
1. mouthpart treatment
While sleeping with special dilator, put into pharyngeal cavity, pharyngeal cavity is expanded, reduce upper airway resistance.When cause is slept, in mouth, will put dilator, have sense of discomfort, patient is difficult for accepting, and easily causes the oral diseases such as xerostomia halitosis.
2. the radio frequency molten therapy that disappears
Be applicable to light moderate patient, utilize plasma low-temperature to eliminate system, make the tissue of pharyngeal hypertrophy subtract to hold and dwindle, the method is easy, and wound is little, not hemorrhage, generally can be in out-patient treatment, but relapse rate is higher.
3. per nasal positive airway pressure
By special respirator, by air pressurized, patient's air flue is blown open, no longer stop up, cure the complication of respiratory tract obstruction anoxia.This method is without wound, but patient need wear nose cup or mask while sleeping, and should, under specialist's guidance, choose and use respirator.Respirator equipment is generally comparatively expensive, wears inconvenience, though because adopting theory of mechanics can significantly improve patient's sleep quality, cannot effect a radical cure symptom.
4. Drug therapy
The medicine of current domestic external enwergy treatment snoring has much, and acetazolamide, thyroxine sheet enhance metabolism, and have certain effect, and period in a medicine can be alleviated, but can not cure, and has side effect.
5. operative treatment
Operative treatment is applicable to unnecessary soft tissue deformity (amygdala hypertrophy, obese patient's soft palate, glossauxeis etc.) and sclerous tissues deformity (as little micromandibular deformity etc.) and causes the patient that upper respiratory tract is narrow or block.Have wound treatment easily to cause postoperative complication, and Postoperative recurrent rate is higher.
Several therapeutic modalities have drawback and shortcoming separately above.Patient's general adaptedness is not high, even if be decided to be the CPAP respirator of OSAHS treatment goldstandard, and 70% the last abandoning cure of selecting because do not adapt to of patient.
utility model content:
In sum, the purpose of this utility model is in order to overcome the drawback of existing therapeutic modality and shortcoming and a kind of novel obstructive sleep apnea low syndrome instrument to be provided.By the electrode slice output electric-impulse stimulation signal stimulus being attached under patient's chin, temper genioglossus, under chin, skin irritation causes neural excitation and root of the tongue muscle contraction, thereby the plug release symptom of air flue in releasing, long-time use can be repaired the contractility of patient's root of the tongue muscle, the tension force of Airway dilation flesh in raising, reaches and improves even curative effect.
For solving the problems of the technologies described above, the technical solution adopted in the utility model is:
A portable obstructive sleep apnea low syndrome instrument, this therapeutic instrument comprises main frame, output lead and electrode slice, the main frame of this therapeutic instrument is comprised of five modules, comprise central processing module, human-computer interaction module, programmed logical module, supply module and output module; Central processing module is connected with programmed logical module with human-computer interaction module respectively, and programmed logical module is connected with output module, and output module is connected with central processing module, and by output lead connection electrode sheet; Central processing module comprises controls CPU, and human-computer interaction module comprises UICPU, LCDs, real-time clock, buzzer and switch, programmed logical module comprise CPLD.
LCDs selects segment liquid crystal screen to carry out work indication, has end time indication on LCD screen, delay time indication, clock display, the demonstration such as state indication and intensity in treatment.
Supply module is used the lithium battery power supply be nominally 3.7V, and by the chip that boosts, voltage being raised to 12V is that the output module of therapeutic instrument is powered; It is central processing module power supply that the first blood pressure lowering chip is reduced to 5V by the 12V voltage rising from lithium battery; It is programmed logical module power supply that the second blood pressure lowering chip is converted to 3.3V by 5V.
This portable therapeutic device also has real-time clock function, that clock circuit partly adopts is the real-time timepiece chip MCP7940M-I/SN of MICROCHIP company, by simple I2C serial line interface and central processing module, communicate, real-time clock/calendar circuit provides a second date and time information for timesharing day month year, natural law monthly and the natural law in leap year can be adjusted automatically, and when MCP7940M when work very low maintenance data of power consumption and clock information, power is less than 1mW.Adopt main power source and backup battery supply, in the situation that pulling out power supply, by stand-by power supply power supply, keep real-time clock, stand-by power supply adopts button cell to power to MCP7940M, and model is CR2032.
Compared with prior art, tool has the following advantages this utility model: this therapeutic instrument is designed to portable, easy to carry while facilitating patient's out of town trip, to patient's compliance, large, applicable patient crowd is wider, do not use 220V civil power, by battery powered, easy to operate use is simple.
accompanying drawing explanation:
Fig. 1 is structural representation of the present utility model;
Fig. 2 is circuit theory diagrams of the present utility model;
Fig. 3 is power circuit principle figure of the present utility model;
Fig. 4 is real-time clock schematic diagram of the present utility model.
the specific embodiment:
Below in conjunction with drawings and embodiments, this utility model is described in further detail.
As depicted in figs. 1 and 2, a kind of portable obstructive sleep apnea low syndrome instrument, this therapeutic instrument comprises main frame 1, output lead 2 and electrode slice 3, is attached to the electrode slice stimulation of genioglossus of patient's chin portion, alleviates patient's symptom treatment OSAHS.The main frame 1 of this therapeutic instrument is comprised of five modules, comprises central processing module, human-computer interaction module, programmed logical module, supply module and output module.
Central processing module is connected with programmed logical module with human-computer interaction module respectively, and programmed logical module is connected with output module, and output module is connected with central processing module, and by output lead connection electrode sheet; Central processing module comprises controls CPU, and human-computer interaction module comprises UICPU, LCDs (LCD), real-time clock (RTC), buzzer (Buzzer) and switch (Switch), programmed logical module comprise CPLD.Control CPU and CPLD for controlling the detection of voltage and the voltage and current of output.
LCDs selects segment liquid crystal screen to carry out work indication, has end time indication on LCD screen, delay time indication, clock display, the demonstration such as state indication and intensity in treatment.
As shown in Figure 3, supply module is used the lithium battery power supply be nominally 3.7V, and by the chip 4 that boosts, voltage being raised to 12V is that the output module of therapeutic instrument is powered; It is central processing module power supply that the first blood pressure lowering chip 5 is reduced to 5V by the 12V voltage rising from lithium battery; It is programmed logical module power supply that the second blood pressure lowering chip 6 is converted to 3.3V by 5V.
As shown in Figure 4, this portable therapeutic device also has real-time clock function, that clock circuit partly adopts is the real-time timepiece chip MCP7940M-I/SN of MICROCHIP company, by simple I2C serial line interface and central processing module, communicate, real-time clock/calendar circuit provides a second date and time information for timesharing day month year, natural law monthly and the natural law in leap year can be adjusted automatically, and when MCP7940M when work very low maintenance data of power consumption and clock information, power is less than 1mW.Adopt main power source and backup battery supply, in the situation that pulling out power supply, by stand-by power supply power supply, keep real-time clock, stand-by power supply adopts button cell to power to MCP7940M, and model is CR2032.
This utility model is tempered genioglossus by the electrode slice output electric-impulse stimulation signal stimulus being attached under patient's chin, under chin, skin irritation causes neural excitation and root of the tongue muscle contraction, thereby the plug release symptom of air flue in releasing, long-time use can be repaired the contractility of patient's root of the tongue muscle, the tension force of Airway dilation flesh in raising, reaches and improves even curative effect; The muscle contraction of electricity irritation simultaneously consumes the heat of local fat, can reach the effect of fat-reducing, fundamentally solves the symptom causing because of obesity.
Claims (4)
1. a portable obstructive sleep apnea low syndrome instrument, this therapeutic instrument comprises main frame, output lead and electrode slice, it is characterized in that: the main frame of this therapeutic instrument is comprised of five modules, comprise central processing module, human-computer interaction module, programmed logical module, supply module and output module; Central processing module is connected with programmed logical module with human-computer interaction module respectively, and programmed logical module is connected with output module, and output module is connected with central processing module, and by output lead connection electrode sheet; Central processing module comprises controls CPU, and human-computer interaction module comprises UICPU, LCDs, real-time clock, buzzer and switch, programmed logical module comprise CPLD.
2. a kind of portable obstructive sleep apnea low syndrome instrument according to claim 1, is characterized in that: described LCDs is stagewise.
3. a kind of portable obstructive sleep apnea low syndrome instrument according to claim 1, is characterized in that: supply module comprises power supply, the chip that boosts, the first blood pressure lowering chip and the second blood pressure lowering chip.
4. a kind of portable obstructive sleep apnea low syndrome instrument according to claim 1, is characterized in that: real-time clock connects main power source and stand-by power supply.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420079318.9U CN203724635U (en) | 2014-02-25 | 2014-02-25 | Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420079318.9U CN203724635U (en) | 2014-02-25 | 2014-02-25 | Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203724635U true CN203724635U (en) | 2014-07-23 |
Family
ID=51194739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420079318.9U Expired - Fee Related CN203724635U (en) | 2014-02-25 | 2014-02-25 | Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203724635U (en) |
-
2014
- 2014-02-25 CN CN201420079318.9U patent/CN203724635U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3533489A1 (en) | Apparatus for treating sleep apnea | |
| CN104035370B (en) | Sleep monitor system and monitoring method | |
| CN110353874B (en) | Sleep disordered breathing treatment system | |
| US11058349B2 (en) | Non-invasive handling of sleep apnea, snoring and emergency situations | |
| CN113423366A (en) | Method and apparatus for treating sleep apnea | |
| KR101394174B1 (en) | Smart self care electrical stumulus apparatus using bio sensor | |
| CN203724635U (en) | Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus | |
| CN203724634U (en) | Desktop obstructive sleep apnea-hypopnea syndrome therapeutic apparatus | |
| CN201082292Y (en) | Eye-shade device with hypnosis action | |
| CN108324455A (en) | A kind of multi-functional oxygen therapy bed | |
| CN202458887U (en) | Light-emitting diode (LED) timed wakening eyeshade | |
| CN205108022U (en) | Adorae hernia binder is made to comfortable type | |
| CN204767042U (en) | Biological electric excitation therapies appearance of intelligence frequency conversion | |
| CN203724636U (en) | Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus | |
| CN202620428U (en) | Multifunctional sleep guiding instrument | |
| CN205108780U (en) | Laser snore relieving appearance | |
| CN205649738U (en) | Portable OSAHS treatment device that accessible commercial power used | |
| CN202277599U (en) | Brainwave frequency instrument | |
| CN205108025U (en) | Sleep apnea helps appearance | |
| CN103800999A (en) | Obstructive sleep apnea hypopnea syndrome therapeutic apparatus | |
| CN203315307U (en) | Ischemic preconditioning training instrument | |
| CN104207927A (en) | Ischemia preadaptation training instrument | |
| CN209187284U (en) | A kind of beddo for medical treatment | |
| CN106420215A (en) | Intelligent snoring-stop nursing bed, intelligent nursing system and nursing method technical field | |
| CN110694161A (en) | Device for improving memory of old people by means of electroencephalogram sensing pink noise |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |